The page lists 48 projects related to the topic "ema".
# | |||
---|---|---|---|
1 | openMedicine | openMedicine | 2015 |
2 | IF-EBOla | Control of the Ebola Oubreak by both innovative Ultrasensitive Detection of EBOV and therapy | 2014 |
3 | DEALS | Biomarker assay development to expedite ALS experimental therapeutic advancement | 2015 |
4 | VISION DMD | VISION-DMD - Phase 2 Clinical Trials of VBP15: An Innovative Steroid-like Intervention on Duchenne Muscular Dystrophy | 2016 |
5 | IEDAT | Intra Erythrocyte Dexamethasone in the treatment of Ataxia Telangiectasia | 2016 |
6 | H2020MM04 | DC-based immunotherapy to treat Malignant Mesothelioma | 2016 |
7 | PEPTO1 | Feasibility study of a novel treatment for cancer based on a recombinant peptide therapy | 2016 |
8 | AB-Prevention | Highly efficient and eco-innovative probiotic food supplement for antibiotic-associated disorders prevention | 2016 |
9 | PrenatStressAging | Prenatal Stress and Programming of Newborn and Infant Telomere Biology and Cellular Aging | 2016 |
10 | TREGS4DM1 | Commercialization of TREG cells sorting and proliferation in vitro for the production of vaccines for the treatment of type 1 diabetes. | 2016 |
11 | IMPAX | Inline/Instant Measurement for PhArma eXtrusion | 2016 |
12 | RIGVIR | Feasibility study for registration of medicine RIGVIR with the European Medicine Agency | 2016 |
13 | SYNBIOMAN | Demonstration of a synthetic biology-driven biomanufacturing platform for adaptable cost-effective production of high-value low volume biologics opportunities. | 2016 |
14 | REPRISE | Reliable Electromechanical actuator for PRImary SurfacE with health monitoring | 2016 |
15 | TreatER | Clinical study in Parkinson's disease with two unique goals: 1) Proof-of-concept of CDNF protein for disease modification; 2) Validation of clinically tested device for intracerebral drug delivery | 2017 |
16 | PACE | A multicenter phase IIb study using HLA-unmatched allogeneic placenta-derived stromal cells (PLX-PAD) for the treatment of severe critical limb ischemia accompanied by mechanistic studies | 2017 |
17 | TR4EMACS | Flexible Test Rig of Aircraft Control Surfaces powered by EMAs | 2017 |
18 | ESTEEM | Advanced Energy STorage and Regeneration System for Enhanced Energy Management | 2017 |
19 | FASE-LAG | FAil-Safe Electro-mechanical actuation for LAnding Gear | 2017 |
20 | TAIRA | Fault Tolerant Aileron Actuation System for Regional Aircraft | 2017 |
21 | LITMUS | Liver Investigation: Testing Marker Utility in Steatohepatitis | 2017 |
22 | RECOMB | Stem-cell based gene therapy for recombination deficient SCID (RECOMB) | 2018 |
23 | CLINGLIO | A Clinical Phase IIB trial with 2OHOA in patients with newly-diagnosed malignant glioma. | 2017 |
24 | OligoGpivotalCF | A pivotal phase IIb clinical trial of inhaled alginate oligosaccharide (OligoG) for cystic fibrosis | 2018 |
25 | TechnocaP | Innovative technology for capsule filling machines to boost the pharmaceutical manufacturing process | 2018 |
26 | EDROMA | Novel nanomedicine for the treatment of glioma | 2018 |
27 | PAH-HOPE | New hope for the PAH patient: A Novel Therapeutic for Pulmonary Arterial Hypertension (PAH) | 2018 |
28 | KHON2bTREAT | Late Clinical Development of KH176: an innovative orphan drug to reach mitochondrial disease patients & market | 2018 |
29 | denovoSkin | Personalized, bio-engineered skin grafts for the permanent treatment of skin defects. | 2018 |
30 | CLINICOVERY | CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research | 2018 |
31 | denovoSkin | Personalized, bio-engineered skin grafts for the permanent treatment of skin defects | 2018 |
32 | AIMS-2-TRIALS | Autism Innovative Medicine Studies – 2 – Trials | 2018 |
33 | FIBROHALT | Advancing a novel peptide-based therapeutic for pancreatic cancer | 2018 |
34 | ONCOBIOME | Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response. | 2019 |
35 | PHIVIDIAS | Preclinical Human In Vitro Drug Immune Response Analysis Platform | 2019 |
36 | CardioReGenix | CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease | 2019 |
37 | Kinaddict | Vulnerability of esophageal cancer to their addiction to kinase activities: evaluation and prediction of eSCC tumors responsiveness to kinase inhibitors. | 2019 |
38 | TransBioLine | Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease | 2019 |
39 | TUASPA | How does Time Use and availability affect the associations between Activity Space, the environment and Physical Activity among European Adults? | 2019 |
40 | RAPID | The first effective remedy for acute pancreatitis disease | 2019 |
41 | GlycoMabs | Chemoenzymatic glyco-engineering of therapeutic monoclonal antibodies | 2019 |
42 | ECRC | Developing a diverse portfolio of vaccine candidates for Rift Valley Fever, Chikungunya and Ebola | 2019 |
43 | AlternativesToGd | Hyperpolarised MR technologies and molecular probes as alternatives for conventional metal-containing contrast agents for MRI examinations | 2019 |
44 | PEPPER | Industrial-scale plant-based protein production in a cell-free platform | 2019 |
45 | RD-MRI NETWORK | BRIDGING THE GAP BETWEEN ACADEMIA & CLINICAL TRIALS FOR THE DEVELOPMENT OF RARE DISEASE TREATMENTS VIA NUCLEAR MAGNETIC RESONANCE IMAGING (MRI) | 2020 |
46 | Lottare GBM | LOcalized Targeted Therapy to Avoid REcurrent GlioBlastoma Multiforme | 2019 |
47 | IDEA-FAST | Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases | 2019 |
48 | immunoassays | Development of new immunoassays for the diagnosis and prediction of drug-related complement pathology | 2020 |